For a limited time: Get The Solid-State Mindset (digital copy) today.

After 31 Jan 2026 it will be available for purchase from Amazon (ebook + paperback).

Written by Víctor M. Díaz Pérez, co-founder of Solitek

Texto sobre el video

A practical mindset for solid-state development before decisions become expensive

Download a free digital copy of The Solid-State Mindset—a field-tested guide to making better early decisions on solubility, solid forms, particle engineering, and preclinical formulation so your program stays predictable.

Upon submission, you will receive a unique, non-transferable link to download your own personal copy. Sharing, distributing or copying the contents of this book, totally or partially, is strictly forbidden.

What you’ll be able to do after reading

You’ll Learn Inside this BOOK:

Spot solid-state risk signals early—before they become scale-up or formulation emergencies.

Decide when particle size reduction is the right lever—and when it creates new problems.

Make rational choices between polymorph vs salt vs cocrystal based on dose, stability, manufacturability, and timelines.

Connect solid-state work with preclinical exposure outcomes so studies remain interpretable and decision-useful.

Understand how solid-state decisions influence strategy and IP (without turning this into a legal treatise).

Inside the book

Why low-solubility pipelines are now the norm—and what that changes in development thinking.

Solid-state fundamentals: interpretation, pitfalls, and what to do when data is ambiguous.

Practical sections on crystallization, PSD, and early formulation trade-offs.

Case studies: Ritonavir, Gatifloxacin, Paroxetine—patterns you can recognize in your own programs.

Who it’s for

Innovative biotech & discovery-to-clinic teams working under aggressive timelines

CMC, solid-state, analytical, formulation, and process professionals building robust paths to clinic

Generics & IP strategy teams evaluating defensible, technically credible options

About the author

Víctor M. Díaz Pérez is a solid-state and preclinical development specialist and co-founder at Solitek. He supports small-molecule teams with solid-state characterization, crystallization and particle engineering, and development strategy—helping programs reduce uncertainty and make earlier, better decisions.